These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22921696)

  • 41. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary metabolic evaluation of stone formers-a Malaysian perspective.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2012 Sep; 80(3):529-34. PubMed ID: 22578827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 24-Hour urine collection for first time pediatric stone formers: Is it worth it?
    Carnes K; Howe A; Feustel PJ; Listman JA; White M; Kogan BA
    J Pediatr Urol; 2021 Jun; 17(3):387.e1-387.e7. PubMed ID: 33762156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urine calcium/citrate ratio in children with hypercalciuric stones.
    Srivastava T; Winston MJ; Auron A; Alon US
    Pediatr Res; 2009 Jul; 66(1):85-90. PubMed ID: 19287339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis.
    Eisner BH; Thavaseelan S; Sheth S; Haleblian G; Pareek G
    Urology; 2012 Nov; 80(5):1007-10. PubMed ID: 22698470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
    Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
    Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Twenty-four-hour urine constituents in stone formers: a study from the northeast part of Peninsular Malaysia.
    Hussein NS; Sadiq SM; Kamaliah MD; Norakmal AW; Gohar MN
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):630-7. PubMed ID: 23640651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
    McMahon GM; Seifter JL
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):183-8. PubMed ID: 22257797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal phosphate control as a reliable predictive factor of stone recurrence.
    Kim YJ; Kim TH; Yun SJ; Kim ME; Kim WJ; Lee SC
    J Urol; 2009 Jun; 181(6):2566-72; discussion 2572. PubMed ID: 19375105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The intestinal microbiome of children with initial and recurrent nephrolithiasis: A pilot study and exploratory analysis.
    Ellison JS; Atkinson SN; Hayward M; Hokanson E; Sheridan KR; Salzman N
    J Pediatr Urol; 2024 Feb; 20(1):18-25. PubMed ID: 37802717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
    Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
    Ferraro PM; Robertson WG; Johri N; Nair A; Gambaro G; Shavit L; Moochhala SH; Unwin RJ
    QJM; 2015 Jul; 108(7):561-8. PubMed ID: 25524906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.